Please login to the form below

Not currently logged in
Email:
Password:

raloxifene

This page shows the latest raloxifene news and features for those working in and with pharma, biotech and healthcare.

Lilly’s president and chief executive John Lechleiter to retire

Lilly’s president and chief executive John Lechleiter to retire

raloxifene) and antidepressant Cymbalta (duloxetine) have also expired.

Latest news

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics